Back
MaxCyte Stock Price Chart
Sponsored
MXCT
Sponsored
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
17
MXCT
MaxCyte
Last Price:
3.42
Seasonality Move:
-8.13%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MXCT is experiencing slight selling pressure.
MaxCyte Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.53 | Sell |
20-day SMA: | 3.64 | Sell |
50-day SMA: | 3.78 | Sell |
200-day SMA: | 4.21 | Sell |
8-day EMA: | 3.52 | Sell |
20-day EMA: | 3.62 | Sell |
50-day EMA: | 3.78 | Sell |
200-day EMA: | 4.12 | Sell |
MaxCyte Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 39.64 | Sell |
Chaikin Money Flow: | -261880 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.51 - 3.83) | Sell |
Bollinger Bands (100): | (3.67 - 4.39) | Sell |
MaxCyte Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for MaxCyte Stock
Is MaxCyte Stock a Buy?
- MaxCyte share price is 3.42 while MXCT 8-day simple moving average is 3.53, which is a Sell signal.
- The stock price of MXCT is 3.42 while MaxCyte 20-day SMA is 3.64, which makes it a Sell.
- MaxCyte 50-day simple moving average is 3.78 while MXCT share price is 3.42, making it a Sell technically.
- MXCT stock price is 3.42 and MaxCyte 200-day simple moving average is 4.21, creating a Sell signal.
MXCT Technical Analysis vs Fundamental Analysis
MaxCyte Stock Info
Market Cap:
360.75M
Price in USD:
3.42
Share Volume:
890.39K
MaxCyte 52-Week Range
52-Week High:
5.55
52-Week Low:
3.23
Sell
17
MaxCyte (MXCT)
is a Sell
MaxCyte Share Price Forecast
-
What is the MaxCyte stock price today?
The MaxCyte stock price is 3.42 USD today. -
Will MXCT stock go up or go down?
MaxCyte> share price is forecast to RISE/FALL based on technical indicators -
Is MaxCyte overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, MaxCyte is overvalued.
Is MaxCyte Stock a Buy?
- MaxCyte share price is 3.42 while MXCT 8-day exponential moving average is 3.52, which is a Sell signal.
- The stock price of MXCT is 3.42 while MaxCyte 20-day EMA is 3.62, which makes it a Sell.
- MaxCyte 50-day exponential moving average is 3.78 while MXCT share price is 3.42, making it a Sell technically.
- MXCT stock price is 3.42 and MaxCyte 200-day simple moving average is 4.12, creating a Sell signal.
Fundamental Analysis of MaxCyte
Is MaxCyte a good investment?
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.02 per share.
Technical Analysis of MaxCyte
Should I short MaxCyte stock?
- MXCT Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting MaxCyte is a Sell
- MaxCyte Relative Strength Index (RSI) is 39.64, which suggest MaxCyte is oversold
- The Bollinger Bands (25) for MaxCyte is (3.51 - 3.83), which suggest MaxCyte is a Sell
- The Bollinger Bands (100) for MaxCyte is (3.67 - 4.39), which suggest MaxCyte is a Sell
* MaxCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.